<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4433221</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0124823</article-id><article-id pub-id-type="publisher-id">PONE-D-14-09335</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Variation in the Ovine Abomasal Lymph Node Transcriptome between Breeds Known to Differ in Resistance to the Gastrointestinal Nematode</article-title><alt-title alt-title-type="running-head">Suffolk and Texel Ovine Abomasal Transcriptome</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>Albin M.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Good</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hanrahan</surname><given-names>James P.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>McGettigan</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Browne</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Keane</surname><given-names>Orla M.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bahar</surname><given-names>Bojlul</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Jai</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Markey</surname><given-names>Bryan</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lohan</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sweeney</surname><given-names>Torres</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>School of Veterinary Medicine, Veterinary Sciences Centre, University College Dublin, Belfield, Dublin 4, Ireland</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Teagasc Animal &#x00026; Grassland Research and Innovation Centre, Athenry, Co. Galway, Ireland</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Teagasc Animal &#x00026; Grassland Research and Innovation Centre, Grange, Co. Meath, Ireland</addr-line></aff><aff id="aff004"><label>4</label><addr-line>UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sambhara</surname><given-names>Suryaprakash</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Centers for Disease Control and Prevention, UNITED STATES</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: TS JPH BG AMA. Performed the experiments: AMA BB AL BG TS JB. Analyzed the data: AMA PM JM BM OK. Wrote the paper: AMA TS BG JPH BB BM PM JM.</p></fn><corresp id="cor001">* E-mail: <email>torres.sweeney@ucd.ie</email></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>5</issue><elocation-id>e0124823</elocation-id><history><date date-type="received"><day>26</day><month>3</month><year>2014</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2015</year></date></history><permissions><copyright-year>2015</copyright-year><copyright-holder>Ahmed et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0124823.pdf"/><abstract><p>Texel lambs are known to be more resistant to gastrointestinal nematode (GIN) infection than Suffolk lambs, with a greater ability to limit infection. The objectives of this study were to: 1) profile the whole transcriptome of abomasal lymph node tissue of GIN-free Texel and Suffolk lambs; 2) identify differentially expressed genes and characterize the immune-related biological pathways and networks associated with these genes. Abomasal lymph nodes were collected from Texel (n = 6) and Suffolk (n = 4) lambs aged 19 weeks that had been GIN-free since 6 weeks of age. Whole transcriptome profiling was performed using RNA-seq on the Illumina platform. At the time of conducting this study, a well annotated <italic>Ovine</italic> genome was not available and hence the sequence reads were aligned with the <italic>Bovine</italic> (UMD3.1) genome. Identification of differentially expressed genes was followed by pathway and network analysis. The Suffolk breed accounted for significantly more of the differentially expressed genes, (276 more highly expressed in Suffolk v 162 in Texel; P &#x0003c; 0.001). The four most significant differentially expressed pathways were all related to immunity and were classified as: <italic>Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses</italic>, <italic>Activation of IRF by Cytosolic Pattern Recognition Receptors</italic>, <italic>Role of RIG-I-like Receptors in Antiviral Innate Immunity</italic>, and <italic>Interferon Signaling</italic>. Of significance is the fact that all of these four pathways were more highly expressed in the Suffolk. These data suggest that in a GIN-free environment, Suffolk lambs have a more active immune profile relative to the Texel: this immune profile may contribute to the poorer efficiency of response to a GIN challenge in the Suffolk breed compared to the Texel breed.</p></abstract><funding-group><funding-statement>This research has been funded by a Teagasc Walsh Fellowship (<ext-link ext-link-type="uri" xlink:href="http://www.teagasc.ie">www.teagasc.ie</ext-link>). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="5"/><page-count count="17"/></counts></article-meta></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Gastrointestinal nematode (GIN) infection of ruminants is a major economic and health concern, causing substantial loss to livestock producers worldwide. Increasing consumer concerns about drug residues in animal products and the emergence of anthelmintic-resistant nematode species have stimulated efforts to develop alternative strategies to anthelmintic therapy [<xref rid="pone.0124823.ref001" ref-type="bibr">1</xref>], including genetic selection for natural resistance to nematodes. The latter approach is justified by evidence of genetic variation in resistance to GIN infection both within and between sheep breeds [<xref rid="pone.0124823.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pone.0124823.ref006" ref-type="bibr">6</xref>].</p><p>The identification of genetically resistant animals through DNA analysis has been focused, to date, on the identification and characterization of candidate genes such as the major histocompatiblity complex (MHC) <italic>DRB</italic> [<xref rid="pone.0124823.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0124823.ref007" ref-type="bibr">7</xref>], MHC class I and II genes [<xref rid="pone.0124823.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0124823.ref009" ref-type="bibr">9</xref>] and interferon gamma [<xref rid="pone.0124823.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0124823.ref011" ref-type="bibr">11</xref>], all of which have alleles that have been associated with resistance to GIN. A weakness of the candidate gene approach is that resistance/susceptibility to GIN is a complex trait with genetic control being polygenic. Our hypothesis is that biochemical pathways and networks are central to differences in resistance and, thus, identification of these will provide a more secure foundation for the elucidation of gene profiles associated with resistance to GIN. Others have shown that a number of genes/biological processes are differentially expressed in duodenal tissue from two lines of lambs selected for divergence in resistance to GIN [<xref rid="pone.0124823.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0124823.ref013" ref-type="bibr">13</xref>].</p><p>Previous studies from our group have shown that the Texel breed is more resistant to GIN infection than the Suffolk breed [<xref rid="pone.0124823.ref014" ref-type="bibr">14</xref>]. Comparing the gastrointestinal lymph tissue transcriptome between Texel and Suffolk in the absence of a GIN challenge should allow the identification of gene pathways and networks that are differentially expressed between the two breeds and thus likely to be involved in the response to a GIN challenge. An understanding of the molecular basis for such breed variation may reveal markers associated with resistance to pathogens. Hence, the objectives of the present study were: 1) to profile the whole transcriptome of abomasal lymph node tissue of GIN-free Texel and Suffolk lambs; and 2) to identify the differentially expressed genes and characterize the immune-related biological pathways and networks associated with the difference in resistance between the Texel and Suffolk breeds. As a well annotated <italic>Ovine</italic> genome was not released at the time of conducting this study we aligned the transcriptome with that of the UMD3.1 <italic>Bos taurus</italic> genome.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Ethics statement</title><p>All procedures described in this experiment were conducted under experimental license (B100/2584) from the Irish Department of Health in accordance with the Cruelty to Animals Act 1876 and the European Communities (Amendments of the Cruelty to Animals Act 1976) Regulations, 2002 and 2005) and approved by the Teagasc Ethics Committee (5909).</p></sec><sec id="sec004"><title>Animals</title><p>The lambs described here were part of a larger experiment concerning the response of Suffolk and Texel lambs to experimental infection with Teladorsagia circumcincta [<xref rid="pone.0124823.ref015" ref-type="bibr">15</xref>]. Lambs (10 in total; 6 Texel and 4 Suffolk) were born (28th and 29th March) indoors, and moved to pasture until 6 weeks of age (mid-May), at which point they were weaned and moved and kept indoors until mid-September. Given that <italic>Nematodirus battus</italic> was the predominant species observed in FEC in lambs after housing (all lambs, data not shown), it was the predominant species on pasture. Animals were maintained indoors on a concentrate-based diet, with free access to water, from mid-May to mid-September. The lambs were faecal sampled per rectum at weaning but sufficient material was obtained from only 7 individuals (4 Texel and 3 Suffolk). Nematodirus eggs were detected in all cases (17, 50, 150, 1700 e.p.g. for Texel and 22, 300, 1000 e.p.g. for Suffolk) while eggs from other Trichostrongyle spp (excluding <italic>S</italic>. <italic>papillosus</italic>) were detected in 4 cases (1, 17, 100 e.p.g. for Suffolk and 50 e.p.g. for one Texel). All lambs were then treated with Ivermectin (Oramec, Merial Animal Health Limited) according to the manufacturer&#x02019;s instructions and quarantined in a slatted pen for 48 h prior to being penned on straw. Faecal samples were collected on 3 consecutive days 5 weeks post-housing/anthelmintic treatment to determine GIN infection status. No eggs were detected in the faecal material of any of the 10 lambs at this stage. The lambs were faecal sampled again one week prior to slaughter to confirm their trichostrongyle infection-free status for at least 13 weeks prior to slaughter.</p></sec><sec id="sec005"><title>Tissue samples</title><p>At the end of the experiment, all ten animals were slaughter by electrical stunning followed by exsanguination. Immediately after slaughter, animals were dissected and approximately 1 g of abomasal lymph node was stored from each animal at room temperature for 24 h in 10 mL RNAlater (Ambion, Austin, TX, USA). RNAlater was then discarded and samples were stored at -80&#x000b0;C until RNA was isolated.</p></sec><sec id="sec006"><title>RNA extraction</title><p>A representative subsample (40 to 50 mg) of the abomasal lymph node tissue was homogenized in 1 mL of TRIreagent (MRC, Cincinnati, OH, USA), using the Qiagen TissueLyzer, and total RNA was extracted following the manufacturer&#x02019;s instructions. DNase I (Sigma-Aldrich, St Louis, MO, USA) treatment of the RNA was then performed and further purification was carried out using the GenElute mammalian total RNA miniprep kit (Sigma-Aldrich, St Louis, MO, USA). The quantity and quality of total RNA were assessed using a Nano Drop spectrophotometer (Thermo Fisher Scientific, USA) and an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc. CA, USA), respectively. All RNA samples used in this study had an RNA integrity value &#x02265; 8.0.</p></sec><sec id="sec007"><title>RNA-seq library preparation</title><p>An RNA-seq library was prepared from ~2 &#x003bc;g of total RNA using an Illumina TruSeq RNA Sample Prep Kit (Cat. No FC-122-1001; Illumina Inc., San Diego, CA, USA) according to the manufacturer&#x02019;s protocol. A multiplexing-capable kit was used for sample multiplexing. The final concentration of the libraries was assessed using a Qubit fluorometer (Invitrogen, Paisley, UK) and quality was assessed using a high sensitivity DNA kit (Agilent Technologies, Inc. CA, USA). The high sensitivity DNA chip and the Agilent 2100 Bioanalyzer were used for library sizing and final validation. One RNA-seq library was prepared from abomasal lymph node tissue from each animal.</p></sec><sec id="sec008"><title>Sequencing</title><p>Equi-molar quantities (10 nM) of the bar-coded cDNA libraries were multiplexed and run in 6 lanes across three flow cells. The sequencing was carried out using Illumina&#x02019;s Genome Analyzer II (Illumina Inc., San Diego, CA, USA) according to the manufacturer&#x02019;s instructions. The sequencing products consisted of single-end reads of 36 nucleotides plus the 6-nucleotide index marker (42 bases in total). FastQC [<xref rid="pone.0124823.ref016" ref-type="bibr">16</xref>] software was used to assess the quality of the sequence data; sequences with a Phred mapping quality score &#x02265; 30 were used for further analysis. This quality score threshold corresponds to base call accuracy of 99.9% [<xref rid="pone.0124823.ref017" ref-type="bibr">17</xref>]. As the quality of the sequence data was very good we did not trim the raw sequences during the processing of data, and thus the length of raw and processed reads were same.</p></sec><sec id="sec009"><title>Data analysis</title><p>As a well annotated <italic>Ovine</italic> genome was not released at the time of conducting this study we aligned the transcriptome with that of <italic>Bovine</italic>. The alignment software Bowtie 0.12.7 [<xref rid="pone.0124823.ref018" ref-type="bibr">18</xref>] was used to align the reads to the UMD3.1 <italic>Bos taurus</italic> genome assembly allowing up to two mismatches per read. Only uniquely aligned reads were used for the analyses. The binary alignment/map (BAM) files from the Bowtie mapping were sorted and filtered for duplications (possibly resulting from PCR bias) using SAMtools [<xref rid="pone.0124823.ref019" ref-type="bibr">19</xref>]. The raw counts, per gene were estimated by HTseq (v0.4.7) (<ext-link ext-link-type="uri" xlink:href="http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html#">http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html#</ext-link>). The data were normalized in edgeR [<xref rid="pone.0124823.ref020" ref-type="bibr">20</xref>] using the trimmed mean of M values (TMM) method [<xref rid="pone.0124823.ref021" ref-type="bibr">21</xref>]. Only genes with &#x02265; 5 reads in total, across all samples, were included in the final analysis. The normalized raw counts per gene were used to identify genes that were differentially expressed (DE) between breeds using edgeR. Gene ontology (GO) of DE genes was performed using GO-Elite [<xref rid="pone.0124823.ref022" ref-type="bibr">22</xref>]. Classification of functional processes of biological importance and of canonical pathways and networks of DE genes were performed using Ingenuity Systems Pathway Analysis (IPA; Ingenuity Systems, Redwood City, CA, USA; <ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com">http://www.ingenuity.com</ext-link>). Data has been made publically available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43241">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43241</ext-link>.</p><p>As some of the most significant differentially expressed pathways suggested that the animals may have been infected with a virus, the RNA-seq data were further aligned with the reference genomes of a number of different viral species [orf virus (HM133903.1) virus, jaagsiekte sheep retrovirus (NC_001494.1), Schmallenberg (NC_018459.1), bluetongue virus (NC_006023.1)]. Moreover, the findings of alignment (presence of orf virus) were further confirmed by using conventional polymerase chain reaction. Genomic DNA was prepared from 100 mg of abomasal lymph node tissue samples. Amplification of orf virus was carried out according to Inoshima <italic>et al</italic>. [<xref rid="pone.0124823.ref023" ref-type="bibr">23</xref>]. The forward- (5'GCGAGTCCGAGAAGAATACG3') and reverse (5'TACGTGGGAAGCGCCTCGCT3') primers bind to a target region specific to the major envelope protein (B2L) gene of orf virus isolate SV178/12 and yielding a PCR product of 594 bp. The reaction conditions and PCR cycling conditions are as described by Inoshima <italic>et al</italic>. [<xref rid="pone.0124823.ref023" ref-type="bibr">23</xref>].</p></sec><sec id="sec010"><title>Validation by quantitative real time PCR (qPCR)</title><p>To validate the results of RNA-seq analysis, a panel of differentially expressed genes was selected from the RNA sequence database and qPCR assays were designed to confirm the direction and magnitude of the expression profiles. Ten genes were randomly selected from the panel of 27 DE genes identified and classified as part of the genetic network &#x02018;<italic>Infectious Disease</italic>, <italic>Antimicrobial Response</italic>, <italic>Inflammatory Response</italic>&#x02019;. Gene specific primers were designed using Primer Express (v2.0) (PE Applied Biosystems) software and were synthesized by Sigma Aldrich, USA. The details of the primers are in <xref rid="pone.0124823.t001" ref-type="table">Table 1</xref>.</p><table-wrap id="pone.0124823.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.t001</object-id><label>Table 1</label><caption><title>Nucleotide sequence of primers used for quantitative real time PCR.</title></caption><alternatives><graphic id="pone.0124823.t001g" xlink:href="pone.0124823.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene category</th><th align="left" rowspan="1" colspan="1">Gene Symbol</th><th align="left" rowspan="1" colspan="1">Sequence (5<sup>/</sup> to 3<sup>/</sup>)</th><th align="left" rowspan="1" colspan="1">Product (bp)</th></tr></thead><tbody><tr><td rowspan="8" align="left" colspan="1">Reference genes</td><td align="left" rowspan="1" colspan="1"><italic>PGK1</italic></td><td align="left" rowspan="1" colspan="1">TTGGCACTGCTCACCGAGCC TCGGGGCTCTCCAAGGCCTT</td><td align="left" rowspan="1" colspan="1">118</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RPL19</italic></td><td align="left" rowspan="1" colspan="1">ATGCCAACTCCCGCCAGCAG CTTCCGGCGAGCCAAGGTGT</td><td align="left" rowspan="1" colspan="1">116</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>GAPDH</italic></td><td align="left" rowspan="1" colspan="1">ATGCCTCCTGCACCACCA AGTCCCTCCACGATGCCAA</td><td align="left" rowspan="1" colspan="1">76</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>B2M</italic></td><td align="left" rowspan="1" colspan="1">TTCTGTCCCACGCTGAGTTCA CAACCCAAATGAGGCATCGT</td><td align="left" rowspan="1" colspan="1">149</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TBP</italic></td><td align="left" rowspan="1" colspan="1">GACCATTGCACTTCGTGCCCG CTCTTGGCTCCCGTGCACACC</td><td align="left" rowspan="1" colspan="1">135</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ACTB</italic></td><td align="left" rowspan="1" colspan="1">CGCAGACAGGATGCAGAAAGA GCTGATCCACATCTGCTGGAA</td><td align="left" rowspan="1" colspan="1">148</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>GUSB</italic></td><td align="left" rowspan="1" colspan="1">CTCATCGTTGGTGCCAATGCAAGT TCACATCCACCCTGGGAAACAGAA</td><td align="left" rowspan="1" colspan="1">193</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ATPSynth</italic></td><td align="left" rowspan="1" colspan="1">TCCTGCTCTGATCCGTTCTT GGCCACTGCTGTAGGAAGG</td><td align="left" rowspan="1" colspan="1">107</td></tr><tr><td rowspan="10" align="left" colspan="1">Target genes</td><td align="left" rowspan="1" colspan="1"><italic>EPCAM</italic></td><td align="left" rowspan="1" colspan="1">AATGGTGAACTACTGGATCTG CCACAATGACGGCAATAATAC</td><td align="left" rowspan="1" colspan="1">115</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IFIT1</italic></td><td align="left" rowspan="1" colspan="1">GAAGAAGCACTGACTGATGAG TGGATTATTTGTGACTTGTAGCA</td><td align="left" rowspan="1" colspan="1">182</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ISG-54</italic></td><td align="left" rowspan="1" colspan="1">CAGAGACTAATAAGACACGCTAT TTCTTCATACTGACCGACTTG</td><td align="left" rowspan="1" colspan="1">120</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IFIT3</italic></td><td align="left" rowspan="1" colspan="1">TCCATACCAAACAATGCCTAC AGTTCTTCAATCTCCTCTCCTT</td><td align="left" rowspan="1" colspan="1">122</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IFIT5</italic></td><td align="left" rowspan="1" colspan="1">TCCAGAGATTGACTGTGAGAA TCAGAATCATCCAGCCGATA</td><td align="left" rowspan="1" colspan="1">162</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MDA-5</italic></td><td align="left" rowspan="1" colspan="1">GTCGTCGGATGGGAGTTT GATGTACCTTTTCACTCTGGC</td><td align="left" rowspan="1" colspan="1">79</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>OAS1</italic></td><td align="left" rowspan="1" colspan="1">TCTTCCTCACCAATCTCACA GACCTCAAACTTCACTTCAAATG</td><td align="left" rowspan="1" colspan="1">125</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RIG-I</italic></td><td align="left" rowspan="1" colspan="1">GATGAATGTCACAACACCAAT GCAATGAGTCTGAAGATCCT</td><td align="left" rowspan="1" colspan="1">94</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RSAD2</italic></td><td align="left" rowspan="1" colspan="1">TAATCTGTAGCCCATACTGACTAT AACTCCATCACAAAGCGTAAA</td><td align="left" rowspan="1" colspan="1">106</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MX1</italic></td><td align="left" rowspan="1" colspan="1">ATGGTTCTTTCTGACTTGGAT CCTTGGACTCCGTTTCAT</td><td align="left" rowspan="1" colspan="1">100</td></tr></tbody></table></alternatives></table-wrap><p>Complementary DNA (cDNA) was synthesized from 1 &#x003bc;g of purified total RNA using cDNA Synthesis Kit (Fermentas, Vilnius, Lithuania) and oligo dT primers following the manufacturer&#x02019;s instructions. The primer efficiency was determined using a serial dilution (1:4 dilution series over 7 points) of a cDNA pool, prepared by pooling an equal quantity of cDNA from all of the experimental samples; the efficiency of all primers was shown to be between 90% to 110%. The reaction was carried out in a total volume of 20 &#x003bc;L, which comprised 10 &#x003bc;L 2X Fast SYBR green PCR Master Mix (Life Technologies), 1 &#x003bc;L of forward and reverse primer mix (final concentration 300 nM each), 1 &#x003bc;L of diluted cDNA template (equivalent to 2.5 ng of RNA) and 8 &#x003bc;L of nuclease-free water (Sigma-Aldrich, St Louis, MO, USA), in an ABI Prism 7500 FAST sequence detection system (Applied Biosystems, Warrington, UK). The PCR cycling conditions were 95&#x000b0;C for 10 min for 1 cycle followed by 95&#x000b0; C for 3 sec and 60&#x000b0; C for 30 sec for 40 cycles. The specificity of the product was confirmed by melt curve analysis.</p><p>Following analysis of the relative quantities of the gene transcripts of 8 potential reference genes (<italic>GAPDH</italic>, <italic>B2M</italic>, <italic>PGK1</italic>, <italic>ATPsynth</italic>, <italic>RPL19</italic>, <italic>TBP</italic>, <italic>GUSB</italic>, <italic>ACTB</italic>) with the GeNorm application within the qBase<sup>PLUS</sup> software package [<xref rid="pone.0124823.ref024" ref-type="bibr">24</xref>] (Biogazelle, Zwijnaarde, Belgium), two robust reference genes (<italic>PGK1</italic> and <italic>RPL19)</italic> were selected for normalization of the relative expression of the target genes. Calibrated normalized relative quantities of gene expression for each target gene were generated using qBase<sup>PLUS</sup>. RNAseq and qPCR data were compared by calculating the correlation coefficient for specific genes after accounting for breed effects using SAS v9.1.3 (SAS Institute, Cary, NC, USA).</p></sec></sec><sec id="sec011"><title>Results and Discussion</title><p>An average of 13 (s.d. 1.9) million reads were generated per sample. Due to the lack of a well-annotated <italic>Ovine</italic> genome at the time of conducting this study, reads were aligned to the bovine sequence, which was the closest species with a well-annotated genome. Alignment of these reads to the <italic>Bos taurus</italic> genome yielded an average of 7 (s.d. 1.1) million uniquely aligned reads per sample, which were subsequently used in the analysis.</p><sec id="sec012"><title>Differentially expressed genes and validation of RNA-seq data</title><p>Based on a false discovery rate &#x0003c; 0.05, a total of 437 DE genes were identified. The gene expression patterns, in terms of direction and magnitude, of all 10 genes chosen for validation were reproducible by qPCR analysis (<xref rid="pone.0124823.g001" ref-type="fig">Fig 1</xref>). Of the DE genes, 276 were more highly expressed in Suffolk while 161 were more highly expressed in Texel. The proportion of DE genes was significantly associated with breed (P &#x0003c; 0.001).</p><fig id="pone.0124823.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g001</object-id><label>Fig 1</label><caption><title>Validation of RNA-seq data using quantitative real time PCR.</title><p>Clear bar shows the Texel breed and the black bar represents Suffolk breed. Error bars show the standard error of the mean. Pearson correlation coefficient (r) values within breed effect (P&#x0003c;0.001 for all comparisons) are shown between the RNA-seq and qPCR charts.</p></caption><graphic xlink:href="pone.0124823.g001"/></fig></sec><sec id="sec013"><title>Gene-ontology analysis of differentially expressed genes</title><p>Functional annotation classification of the 276 genes more highly expressed in the Suffolk breed yielded a total of 59 significant (P&#x0003c; 0.05) functional annotation clusters; the 10 most significant clusters are presented in <xref rid="pone.0124823.t002" ref-type="table">Table 2</xref>. The majority of the functional annotation clusters in the Suffolk relate to the immune system, including: <italic>ISG15-protein conjugation</italic>, <italic>Immune response</italic>, <italic>Antigen processing and presentation of peptide antigen via MHC class I</italic>, <italic>Response to other organism</italic>, <italic>Defence response</italic>, <italic>MHC class I protein complex</italic>, <italic>Regulation of interleukin-10 production</italic>, <italic>Chemokine activity and Type I interferon biosynthetic process</italic>. The most significant group, <italic>ISG15-protein conjugation</italic>, contains 4 genes, whereas the two largest clusters <italic>Immune response</italic> and <italic>Defence response</italic> comprise 31 and 21 genes, respectively. In the Texel breed, a total of 26 significant (P &#x0003c; 0.05) functional annotation clusters were identified and the 10 most significant clusters are presented in <xref rid="pone.0124823.t003" ref-type="table">Table 3</xref>. The GO terms associated with highly expressed genes in the Texel breed describe normal cellular processes and include: <italic>Vitamin transport</italic>, <italic>Regulation of smooth muscle cell proliferation</italic>, <italic>Collagen fibril organization</italic>, <italic>Proteinaceous extracellular matrix</italic>, <italic>Extrinsic to plasma membrane</italic>, <italic>Extracellular space</italic>, <italic>Glucose metabolic process and Cell-cell adhesion</italic>.</p><table-wrap id="pone.0124823.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.t002</object-id><label>Table 2</label><caption><title>Major functional annotation clusters (top 10 annotation clusters based on z-score) of genes that were differentially expressed in Suffolk breed.</title></caption><alternatives><graphic id="pone.0124823.t002g" xlink:href="pone.0124823.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">GO name</th><th align="left" rowspan="1" colspan="1">Number of genes</th><th align="left" rowspan="1" colspan="1">z-score</th><th align="left" rowspan="1" colspan="1">Genes names</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ISG15\-protein conjugation</td><td align="left" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">16.47</td><td align="left" rowspan="1" colspan="1"><italic>USP18</italic>, <italic>UBA7</italic>, <italic>UB2L6</italic>, <italic>ISG15</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Immune response</td><td align="left" rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">9.59</td><td align="left" rowspan="1" colspan="1"><italic>RIG-I</italic>, <italic>LAG3</italic>, <italic>C1QB</italic>, <italic>IL1A</italic>, <italic>TBK1</italic>, <italic>RSAD2</italic>, <italic>OAS2</italic>, <italic>OAS1</italic>, <italic>CXL10</italic>, <italic>CTLA-4</italic>, <italic>MHC-I</italic>, <italic>C1QC</italic>, <italic>TNFRSF4</italic>, <italic>CCL22</italic>, <italic>BOLA</italic>, <italic>A6QQE3</italic>, <italic>IDO1</italic>, <italic>ANXA3</italic>, <italic>MIC</italic>, <italic>CACB3</italic>, <italic>CCL20</italic>, <italic>CCL8 oas1z</italic>, <italic>CD40L</italic>, <italic>FCERG</italic>, <italic>JSP1</italic>, <italic>Q3YFG6</italic>, <italic>Q9TSB2</italic>, <italic>Q9TUD0</italic>, <italic>REG1</italic>, <italic>TNFSF10</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma membrane organization</td><td align="left" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">9.23</td><td align="left" rowspan="1" colspan="1"><italic>AGRN</italic>, <italic>DYSF</italic>, <italic>MYOF</italic>, <italic>Q9TUD0</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Antigen processing and presentation of peptide antigen via MHC class I</td><td align="left" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">8.84</td><td align="left" rowspan="1" colspan="1"><italic>BOLA</italic>, <italic>FCERG</italic>, <italic>JSP1</italic>, <italic>Q3YFG6</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Response to other organism</td><td align="left" rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">7.55</td><td align="left" rowspan="1" colspan="1"><italic>STAT4</italic>, <italic>RIG-I</italic>, <italic>MX1</italic>, <italic>MX2</italic>, <italic>IRF3</italic>, <italic>TBK1</italic>, <italic>RSAD2</italic>, <italic>ISG20</italic>, <italic>A6QQE3</italic>, <italic>IDO1</italic>, <italic>ANXA3</italic>, <italic>FCERG</italic>, <italic>LYSCN</italic>, <italic>Q9TUD0</italic>, <italic>UCRP</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Defence response</td><td align="left" rowspan="1" colspan="1">21</td><td align="char" char="." rowspan="1" colspan="1">7.16</td><td align="left" rowspan="1" colspan="1"><italic>RSAD2</italic>, <italic>TBK1</italic>, <italic>RIG-I</italic>, <italic>IFI47</italic>, <italic>IL1A</italic>, <italic>LAG3</italic>, <italic>C1QB</italic>, <italic>TNFRSF4</italic>, <italic>CCR4</italic>, <italic>A6QQE3</italic>, <italic>IDO1</italic>, <italic>ANXA3</italic>, <italic>CCL20</italic>, <italic>CCL8</italic>, <italic>CD40L</italic>, <italic>CXL10</italic>, <italic>FCERG</italic>, <italic>LYSCN</italic>, <italic>Q56J78</italic>, <italic>Q9TUD0</italic>, <italic>REG1</italic>,</td></tr><tr><td align="left" rowspan="1" colspan="1">MHC class I protein complex</td><td align="left" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">6.97</td><td align="left" rowspan="1" colspan="1"><italic>BOLA</italic>, <italic>B2MWQ2</italic>, <italic>MHC-I</italic>, <italic>JSP1</italic>, <italic>Q3YFG6</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Cellular response to heat</td><td align="left" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">6.52</td><td align="left" rowspan="1" colspan="1"><italic>IL1A</italic>, <italic>MYOF</italic>, <italic>TFEC</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Regulation of interleukin\-10 production</td><td align="left" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">6.25</td><td align="left" rowspan="1" colspan="1"><italic>IDO1 FCERG</italic>, <italic>TRIB2</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Chemokine activity</td><td align="left" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">6.04</td><td align="left" rowspan="1" colspan="1"><italic>CCL22</italic>, <italic>CCL20</italic>, <italic>CCL8</italic>, <italic>CXL10</italic>, <italic>REG1</italic></td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone.0124823.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.t003</object-id><label>Table 3</label><caption><title>Major functional annotation clusters (top 10 annotation clusters based on z-score) of up-regulated genes in Texel breed.</title></caption><alternatives><graphic id="pone.0124823.t003g" xlink:href="pone.0124823.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">GO name</th><th align="left" rowspan="1" colspan="1">Number of genes</th><th align="left" rowspan="1" colspan="1">z-score</th><th align="left" rowspan="1" colspan="1">Gene names</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Vitamin transport</td><td align="left" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">9.40</td><td align="left" rowspan="1" colspan="1"><italic>RET4</italic>, <italic>SLC22A16</italic>, <italic>TCN2</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Regulation of smooth muscle cell proliferation</td><td align="left" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">7.43</td><td align="left" rowspan="1" colspan="1"><italic>CAD13</italic>, <italic>CALRL</italic>, <italic>IBP5</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Collagen fibril organization</td><td align="left" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">6.78</td><td align="left" rowspan="1" colspan="1"><italic>COBA1</italic>, <italic>DERM</italic>, <italic>TNXB</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Proteinaceous extracellular matrix</td><td align="left" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">6.05</td><td align="left" rowspan="1" colspan="1"><italic>TNC</italic>, <italic>COBA1</italic>, <italic>DERM</italic>, <italic>FMOD</italic>, <italic>MFAP5</italic>, <italic>TNXB</italic>, <italic>PGS2</italic>, <italic>GPC1</italic>, <italic>POSTN</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Extrinsic to plasma membrane</td><td align="left" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">4.58</td><td align="left" rowspan="1" colspan="1"><italic>GBG7</italic>, <italic>SCUBE1</italic>, <italic>ST14</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Extracellular space</td><td align="left" rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">4.16</td><td align="left" rowspan="1" colspan="1"><italic>TNC</italic>, <italic>A2M</italic>, <italic>ECM1</italic>, <italic>ADIPO</italic>, <italic>CAD13</italic>, <italic>DERM</italic>, <italic>FMOD</italic>, <italic>TNXB</italic>, <italic>PGS2</italic>, <italic>RET4</italic>, <italic>SCUBE1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Extracellular matrix part</td><td align="left" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">3.97</td><td align="left" rowspan="1" colspan="1"><italic>TNC</italic>, <italic>COBA1</italic>, <italic>MFAP5</italic>, <italic>TNXB</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Cell projection assembly</td><td align="left" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">3.90</td><td align="left" rowspan="1" colspan="1"><italic>KLF5</italic>, <italic>CAD13</italic>, <italic>PKHD1</italic>, <italic>VANGL2</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose metabolic process</td><td align="left" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">3.56</td><td align="left" rowspan="1" colspan="1"><italic>ADIPO</italic>, <italic>DCXR</italic>, <italic>PGM1</italic>, <italic>RET4</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Cell\-cell adhesion</td><td align="left" rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">3.50</td><td align="left" rowspan="1" colspan="1"><italic>CDH17</italic>, <italic>ADIPO</italic>, <italic>CAD13</italic>, <italic>CLD1</italic>, <italic>COBA1</italic>, <italic>TNXB</italic>, <italic>PKHD1</italic></td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec014"><title>Identification of pathways and gene interaction networks</title><sec id="sec015"><title>Pathway analysis</title><p>A total of 23 significantly over-represented canonical pathways were identified as differentially expressed between GIN-free Texel and Suffolk sheep (<xref rid="pone.0124823.t004" ref-type="table">Table 4</xref>). The four most significant pathways all relate to processes of anti-viral /anti-bacterial innate immunity and were all more highly expressed in the Suffolk lambs relative to the Texel lambs. The four pathways and the DE genes assigned to each pathway are as follows:
<list list-type="bullet"><list-item><p><italic>Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses</italic>: <italic>RIG-I</italic>, <italic>MDA-5</italic>, <italic>DECTIN-2</italic>, <italic>IRF3</italic>, <italic>OAS1</italic>, <italic>OAS2</italic>, <italic>C1QC</italic>, <italic>C1QB</italic>, <italic>EIF2AK2</italic>, <italic>RNASEL</italic>, <italic>C3AR1</italic> (<xref rid="pone.0124823.g002" ref-type="fig">Fig 2</xref>);</p></list-item><list-item><p><italic>Activation of IRF by Cytosolic Pattern Recognition Receptors</italic>: <italic>RIG-I</italic>, <italic>MDA-5</italic>, <italic>DAI</italic>, <italic>ISG-54</italic>, <italic>TBK1</italic>, <italic>IRF3</italic>, <italic>IRF9</italic>, <italic>STAT2</italic>, <italic>ADAR1</italic>, <italic>ISG15</italic> (<xref rid="pone.0124823.g003" ref-type="fig">Fig 3</xref>);</p></list-item><list-item><p><italic>Role of RIG-I-like Receptors in Antiviral Innate Immunity</italic>: <italic>RIG-I</italic>, <italic>MDA-5</italic>, <italic>TBK1</italic>, <italic>IRF3</italic>, <italic>TRIM2</italic>, (<xref rid="pone.0124823.g004" ref-type="fig">Fig 4</xref>);</p></list-item><list-item><p><italic>Interferon Signaling</italic>: <italic>IFIT1</italic>, <italic>IFIT3</italic>, <italic>IRF9</italic>, <italic>OAS1</italic>, <italic>MX1</italic>, <italic>STAT</italic>, (<xref rid="pone.0124823.g005" ref-type="fig">Fig 5</xref>).</p></list-item></list>
</p><fig id="pone.0124823.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g002</object-id><label>Fig 2</label><caption><title>Schematic representation of the <italic>Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses</italic> pathway from IPA.</title><p>Genes within the pathway showing differential expression are highlighted in colour. The colour intensity indicates the degree of elevated expression in Suffolk (red) or in Texel (green). Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not represented on the RNA-seq data.</p></caption><graphic xlink:href="pone.0124823.g002"/></fig><fig id="pone.0124823.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g003</object-id><label>Fig 3</label><caption><title>Schematic representation of the <italic>Activation of IRF by Cytosolic Pattern Recognition Receptors</italic> pathway from IPA.</title><p>Genes within the pathway showing differential expression are highlighted in colour. The colour intensity indicates the degree of elevated expression in Suffolk (red) or in Texel (green). Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not represented on the RNA-seq data.</p></caption><graphic xlink:href="pone.0124823.g003"/></fig><fig id="pone.0124823.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g004</object-id><label>Fig 4</label><caption><title>Schematic representation of the <italic>Role of RIG-I likes receptors in antiviral innate immunity</italic> pathway from IPA.</title><p>Genes within the pathway showing differential expression are highlighted in colour. The colour intensity indicates the degree of elevated expression in Suffolk (red) or in Texel (green). Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not represented on the RNA-seq data.</p></caption><graphic xlink:href="pone.0124823.g004"/></fig><fig id="pone.0124823.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g005</object-id><label>Fig 5</label><caption><title>Schematic representation of the <italic>Interferon Signaling</italic> pathway from IPA.</title><p>Genes within the pathway showing differential expression are highlighted in colour. The colour intensity indicates the degree of elevated expression in Suffolk (red) or in Texel (green). Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not represented on the RNA-seq data.</p></caption><graphic xlink:href="pone.0124823.g005"/></fig><table-wrap id="pone.0124823.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.t004</object-id><label>Table 4</label><caption><title>Gene classification based on canonical signaling pathways identified by Ingenuity pathway analysis (IPA).</title></caption><alternatives><graphic id="pone.0124823.t004g" xlink:href="pone.0124823.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Ingenuity Canonical Pathways</th><th align="left" rowspan="1" colspan="1"><italic>P-values</italic></th><th align="left" rowspan="1" colspan="1">Molecules<xref rid="t004fn001" ref-type="table-fn"><sup>&#x02021;</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Activation of IRF by Cytosolic Pattern Recognition Receptors</td><td align="left" rowspan="1" colspan="1">10.0&#x000d7;10<sup>&#x02013;08</sup></td><td align="left" rowspan="1" colspan="1"><bold><italic>MDA-5</italic>, <italic>RIG-I</italic>, <italic>DAI</italic>, <italic>STAT2</italic>, <italic>IRF9</italic>, <italic>TBK1</italic>, <italic>IRF3</italic>, <italic>ADAR1</italic>, <italic>ISG-54</italic>, <italic>ISG15</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses</td><td align="left" rowspan="1" colspan="1">7.0&#x000d7;10<sup>&#x02013;07</sup></td><td align="left" rowspan="1" colspan="1"><bold><italic>MDA-5</italic>, <italic>OAS1</italic>, <italic>OAS2</italic>, <italic>RIG-I</italic>, <italic>DECTIN-2</italic>, <italic>C1QC</italic>, <italic>C1QB</italic>, <italic>IRF3</italic>, <italic>EIF2AK2</italic>, <italic>RNASEL</italic>, <italic>C3AR1</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Interferon Signaling</td><td align="left" rowspan="1" colspan="1">2.1&#x000d7;10<sup>&#x02013;05</sup></td><td align="left" rowspan="1" colspan="1"><bold><italic>IFIT3</italic>, <italic>IFIT1</italic>, <italic>OAS1</italic>, <italic>MX1</italic>, <italic>STAT2</italic>, <italic>IRF9</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Role of RIG-I-like Receptors in Antiviral Innate Immunity</td><td align="left" rowspan="1" colspan="1">8.7&#x000d7;10<sup>&#x02013;04</sup></td><td align="left" rowspan="1" colspan="1"><bold><italic>MDA-5</italic>, <italic>RIG-I</italic>, <italic>TBK1</italic>, <italic>IRF3</italic>, <italic>TRIM25</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Riboflavin Metabolism</td><td align="left" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1"><italic>FLAD1</italic>, <bold><italic>ENPP1</italic>, <italic>ACP6</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Communication between Innate and Adaptive Immune Cells</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1"><bold><italic>CXCL10</italic>,</bold>
<italic>TLR10</italic>, <bold><italic>CD40LG</italic>, <italic>IL1A</italic>, <italic>HLA-A</italic>, <italic>FCER1G</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Dendritic Cell Maturation</td><td align="left" rowspan="1" colspan="1">0.006</td><td align="left" rowspan="1" colspan="1"><bold><italic>CD40LG</italic>, <italic>IL1A</italic>, <italic>HLA-A</italic>,</bold>
<italic>CD1A</italic>, <bold><italic>FCER1G</italic>, <italic>STAT2</italic>,</bold>
<italic>CREB3L4</italic><bold>, <italic>FCGR3A</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Graft-versus-Host Disease Signaling</td><td align="left" rowspan="1" colspan="1">0.008</td><td align="left" rowspan="1" colspan="1"><bold><italic>IL1A</italic>, <italic>HLA-A</italic>, <italic>FCER1G</italic>, <italic>GZMB</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Autoimmune Thyroid Disease Signaling</td><td align="left" rowspan="1" colspan="1">0.008</td><td align="left" rowspan="1" colspan="1"><bold><italic>CD40LG</italic>, <italic>HLA-A</italic>, <italic>FCER1G</italic>, <italic>GZMB</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatic Fibrosis / Hepatic Stellate Cell Activation</td><td align="left" rowspan="1" colspan="1">0.010</td><td align="left" rowspan="1" colspan="1"><bold><italic>CD40LG</italic>, <italic>IL1A</italic>, <italic>CTGF</italic>,</bold>
<italic>MYL4</italic>, <italic>FGFR2</italic>, <italic>IGFBP5</italic>, <italic>A2M</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">cAMP-mediated signaling</td><td align="left" rowspan="1" colspan="1">0.011</td><td align="left" rowspan="1" colspan="1"><bold><italic>P2RY13</italic>,</bold>
<italic>TULP2</italic>, <bold><italic>PRKAR2B</italic>, <italic>CCR4</italic>, <italic>PDE3B</italic>, <italic>ADCY6</italic>,</bold>
<italic>CREB3L4</italic>, <italic>CNGA3</italic>, <italic>MPPE1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Sphingolipid Metabolism</td><td align="left" rowspan="1" colspan="1">0.012</td><td align="left" rowspan="1" colspan="1"><bold><italic>CERS6</italic>,</bold>
<italic>ARSJ</italic>, <bold><italic>SGPP1</italic>,</bold>
<italic>PPAP2C</italic><bold>, <italic>SMPD3</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">G-Protein Coupled Receptor Signaling</td><td align="left" rowspan="1" colspan="1">0.014</td><td align="left" rowspan="1" colspan="1"><italic>CALCRL</italic>, <bold><italic>GPR15</italic>, <italic>ADCY6</italic>,</bold>
<italic>CREB3L4</italic>, <italic>MPPE1</italic>, <bold><italic>ADRA1D</italic>, <italic>P2RY13</italic>,</bold>
<italic>TULP2</italic>, <bold><italic>PRKAR2B</italic>, <italic>CCR4</italic>, <italic>PDE3B</italic>, <italic>GPR126</italic>, <italic>CCR8</italic>, <italic>HRH4</italic>, <italic>C3AR1</italic>,</bold>
<italic>GPR143</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Altered T Cell and B Cell Signaling in Rheumatoid Arthritis</td><td align="left" rowspan="1" colspan="1">0.016</td><td align="left" rowspan="1" colspan="1"><italic>TLR10</italic>, <bold><italic>CD40LG</italic>, <italic>IL1A</italic>, <italic>SPP1 (includes EG</italic>:<italic>20750)</italic>,<italic>FCER1G</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Complement System</td><td align="left" rowspan="1" colspan="1">0.018</td><td align="left" rowspan="1" colspan="1"><bold><italic>C1QC</italic>, <italic>C1QB</italic>, <italic>C3AR1</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Nitrogen Metabolism</td><td align="left" rowspan="1" colspan="1">0.023</td><td align="left" rowspan="1" colspan="1"><italic>MARC1</italic>, <bold><italic>ADAR</italic>,</bold>
<italic>GLS2</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">NF-&#x003ba;B Signaling</td><td align="left" rowspan="1" colspan="1">0.024</td><td align="left" rowspan="1" colspan="1"><italic>TLR10</italic>, <bold><italic>CD40LG</italic>, <italic>IL1A</italic>, <italic>FCER1G</italic>,</bold>
<italic>FGFR2</italic>, <bold><italic>TBK1</italic>, <italic>EIF2AK2</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac &#x003b2;-adrenergic Signaling</td><td align="left" rowspan="1" colspan="1">0.255</td><td align="left" rowspan="1" colspan="1"><italic>TULP2</italic>, <bold><italic>PRKAR2B</italic>, <italic>PDE3B</italic>, <italic>ADCY6</italic>,</bold>
<italic>GNG7</italic>, <italic>MPPE1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Relaxin Signaling</td><td align="left" rowspan="1" colspan="1">0.026</td><td align="left" rowspan="1" colspan="1"><italic>TULP2</italic>, <bold><italic>PRKAR2B</italic>, <italic>PDE3B</italic>, <italic>ADCY6</italic>,</bold>
<italic>GNG7</italic>, <italic>MPPE1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Alanine and Aspartate Metabolism</td><td align="left" rowspan="1" colspan="1">0.028</td><td align="left" rowspan="1" colspan="1"><italic>DDO</italic>, <bold><italic>AGXT2</italic>,</bold>
<italic>ASL</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Protein Kinase A Signaling</td><td align="left" rowspan="1" colspan="1">0.040</td><td align="left" rowspan="1" colspan="1"><italic>TULP2</italic>, <bold><italic>PRKAR2B</italic>, <italic>ADD2</italic>, <italic>PDE3B</italic>, <italic>ADCY6</italic>,</bold>
<italic>MYL4</italic>, <italic>CREB3L4</italic>, <italic>CNGA3</italic>, <italic>GNG7</italic>, <italic>MPPE1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">VDR/RXR Activation</td><td align="left" rowspan="1" colspan="1">0.044</td><td align="left" rowspan="1" colspan="1"><bold><italic>CXCL10</italic>, <italic>SPP1 (includes EG</italic>:<italic>20750)</italic>, <italic>CYP24A1</italic>,</bold>
<italic>IGFBP5</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Lipid Antigen Presentation by CD1</td><td align="left" rowspan="1" colspan="1">0.049</td><td align="left" rowspan="1" colspan="1"><italic>CD1A</italic>, <bold><italic>FCER1G</italic></bold></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>&#x02021;Genes more highly expressed in the Suffolk breed are in bold while genes that are more highly expressed in the Texel breed are in normal typeface.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec016"><title>Gene interaction networks</title><p>The overall gene interaction networks for the differentially expressed genes were constructed using IPA. A total of 25 significant (P &#x0003c; 0.05) gene interaction networks were identified. The details of the 10 most significant networks are presented in <xref rid="pone.0124823.t005" ref-type="table">Table 5</xref>. The gene interaction network with the highest number of focus molecules (n = 27) was designated <italic>Infectious Disease</italic>, <italic>Antimicrobial Response</italic>, <italic>Inflammatory Response</italic>. This network included 24 genes that were more highly expressed in the Suffolk breed and 3 genes that were more highly expressed in the Texel breed (<xref rid="pone.0124823.g006" ref-type="fig">Fig 6</xref>).</p><fig id="pone.0124823.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g006</object-id><label>Fig 6</label><caption><title>Schematic representation of the <italic>Infectious Disease</italic>, <italic>Antimicrobial Response and Inflammatory Response</italic> interaction network from IPA.</title><p>Genes within the pathway showing differential expression are highlighted in colour. The colour intensity indicates the degree of elevated expression in Suffolk (red) or in Texel (green). Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not represented on the RNA-seq data.</p></caption><graphic xlink:href="pone.0124823.g006"/></fig><table-wrap id="pone.0124823.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.t005</object-id><label>Table 5</label><caption><title>Top 10 gene classifications of molecules in networks using IPA.</title></caption><alternatives><graphic id="pone.0124823.t005g" xlink:href="pone.0124823.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Top functions</th><th align="left" rowspan="1" colspan="1">Molecules<xref rid="t005fn001" ref-type="table-fn"><sup>&#x02021;</sup></xref> in Network</th><th align="left" rowspan="1" colspan="1">Score</th><th align="left" rowspan="1" colspan="1">Focus molecules</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Infectious Disease, Antimicrobial Response, Inflammatory Response</td><td align="left" rowspan="1" colspan="1"><bold><italic>ADAR</italic>,</bold>
<italic>BPI</italic>, <bold><italic>RIG-I</italic>, <italic>EIF2AK2</italic>, <italic>ENPP1</italic>,</bold>
<italic>EPCAM</italic>, <bold><italic>HERC5</italic>, <italic>IFI6</italic>, <italic>IFI27</italic>, <italic>Ifi47</italic>, <italic>MDA-5</italic>, <italic>IFIT1</italic>, <italic>ISG-54</italic>, <italic>IFIT3</italic>, <italic>IFIT5</italic>, <italic>IRF3</italic>, <italic>IRF9</italic>, <italic>IRG</italic>, <italic>ISG15</italic>, <italic>MX1</italic>, <italic>OAS1</italic>, <italic>OAS2</italic>,</bold>
<italic>PASK</italic>, <bold><italic>RSAD2</italic>, <italic>STAT2</italic>, <italic>TNFSF10</italic>, <italic>UBA7</italic></bold></td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">27</td></tr><tr><td align="left" rowspan="1" colspan="1">Tissue Morphology, Cell-To-Cell Signaling and Interaction</td><td align="left" rowspan="1" colspan="1"><bold><italic>AGRN</italic>, <italic>C1QB</italic>, <italic>C1QC</italic>,</bold>
<italic>DCN</italic>, <italic>ELF5</italic>, <bold><italic>ETS2</italic>, <italic>EVI2A</italic>,</bold>
<italic>FMOD</italic>, <bold><italic>GBP7</italic>, <italic>GDF11</italic>,</bold>
<italic>GPC1</italic>, <italic>KLRC1</italic>, <bold><italic>KLRD1</italic>, <italic>LAG3</italic>, <italic>MHC Class I (complex)</italic>, <italic>MRPL44 (includes EG</italic>:<italic>301552)</italic>,</bold>
<italic>MYL4</italic><bold>, <italic>NAIP</italic>,</bold>
<italic>PPAP2C</italic>, <bold><italic>SGPP1</italic>, <italic>SIGLEC1</italic></bold>, <italic>ST14</italic>, <bold><italic>TFEC</italic>, <italic>XAF1</italic></bold></td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">24</td></tr><tr><td align="left" rowspan="1" colspan="1">Connective Tissue Development and Function, Lipid Metabolism, Small Molecule Biochemistry</td><td align="left" rowspan="1" colspan="1"><italic>CDH13</italic>, <italic>CDH17</italic>, <bold><italic>CDH20</italic>,</bold>
<italic>CIDEC</italic>, <bold><italic>CLEC1B</italic>, <italic>DECTIN-2</italic>, <italic>CTLA4</italic>, <italic>FCGR3A</italic>, <italic>ICOS</italic>, <italic>LY6E</italic>,</bold>
<italic>MPPE1</italic>, <bold><italic>PDE3B</italic>,</bold>
<italic>PLIN1</italic>, <bold><italic>PRKAR2B</italic>, <italic>SAA</italic>, <italic>SAMSN1</italic>, <italic>STMN2</italic>,</bold>
<italic>THRSP</italic>, <bold><italic>TRIM21</italic>,</bold>
<italic>TULP2</italic></td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">Gene Expression, Gastrointestinal Disease, Inflammatory Disease</td><td align="left" rowspan="1" colspan="1"><bold><italic>BATF2</italic>, <italic>C1QB</italic>,</bold>
<italic>CDH13</italic>, <bold><italic>CLEC4A</italic>, <italic>CLEC4E</italic>, <italic>CLEC4F</italic>, <italic>CMPK2</italic>, <italic>DDIT4L</italic>, <italic>DTX3L</italic>, <italic>FAM26F</italic>, <italic>HERC6</italic>, <italic>IFI6</italic>, <italic>IL22RA2</italic>,</bold>
<italic>NAALADL1</italic>, <bold><italic>PARP9</italic>, <italic>SAMD9</italic>, <italic>SHISA2</italic>,</bold>
<italic>SLC22A16</italic>, <italic>TMC6</italic></td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">Infectious Disease, Cell-To-Cell Signaling and Interaction, Cellular Movement</td><td align="left" rowspan="1" colspan="1"><bold><italic>ALDH9A1</italic>, <italic>APOL3</italic>,</bold>
<italic>BTN1A1</italic>, <bold><italic>CCL20</italic>, <italic>CCL22</italic>,</bold>
<italic>CLCA1</italic>, <bold><italic>CXCL10</italic>, <italic>IDO1</italic>, <italic>Oas</italic>,</bold>
<italic>PLB1 (includes EG</italic>:<italic>151056)</italic>, <italic>RNASE1</italic>, <bold><italic>RNASEL</italic>, <italic>TBK1</italic>, <italic>TNFRSF4</italic>, <italic>TRIM25</italic>, <italic>UBE2L6</italic>, <italic>USP18</italic>, <italic>DAI</italic></bold></td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="1" colspan="1">Small Molecule Biochemistry, Inflammatory Response, Drug Metabolism</td><td align="left" rowspan="1" colspan="1"><italic>ADIPOQ</italic>, <bold><italic>BST2</italic>, <italic>C1RL</italic>, <italic>CD40LG</italic>,</bold>
<italic>FABP4</italic>, <bold><italic>GSTM1</italic>, <italic>Gstt3</italic>, <italic>HP</italic>, <italic>HPGDS</italic>, <italic>IL1A</italic>, <italic>LYZ</italic>, <italic>PLA2G2A</italic>, <italic>PLSCR1</italic>, <italic>SAA1</italic>, <italic>SERPINE2</italic>, <italic>SPINK5</italic>, <italic>UBD</italic>,</bold>
<italic>VANGL2</italic></td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="1" colspan="1">Tissue Development, Connective Tissue Development and Function, Skeletal and Muscular System Development and Function</td><td align="left" rowspan="1" colspan="1"><italic>ACVR1C</italic>, <bold><italic>ADCY6</italic>, <italic>CACNA1H</italic>,</bold>
<italic>CD1A</italic>, <bold><italic>CTGF</italic>, <italic>CYP24A1</italic>,</bold>
<italic>ECM1 (includes EG</italic>:<italic>100332249)</italic>, <italic>EPHA7</italic>, <bold><italic>FCER1G</italic>,</bold>
<italic>HOMER2</italic>, <italic>IGFBP5</italic>, <italic>KLF5</italic>, <italic>LY9</italic>, <bold><italic>P2RX7</italic>,</bold>
<italic>PAPSS2</italic>, <italic>SH3GL2</italic>, <bold><italic>SMPD3</italic>, <italic>SPP1 (includes EG</italic>:<italic>20750)</italic>,</bold>
<italic>TLR10</italic>, <italic>TNXB</italic></td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function</td><td align="left" rowspan="1" colspan="1"><bold><italic>ACP6</italic>, <italic>ADRA1D</italic>, <italic>ARRDC4</italic>, <italic>C3AR1</italic>,</bold>
<italic>C5orf13</italic>, <italic>CALCRL</italic>, <bold><italic>CCR4</italic>, <italic>CCR8</italic>,</bold>
<italic>GNG7</italic>, <bold><italic>GPR15</italic>, <italic>GPR126</italic>,</bold>
<italic>GPR143</italic><bold>, <italic>HRH4</italic>, <italic>P2RY13</italic>, <italic>RGS1</italic>, <italic>WARS</italic></bold></td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry</td><td align="left" rowspan="1" colspan="1"><italic>ACRBP</italic>, <bold><italic>CERS6</italic>,</bold>
<italic>CIDEC</italic>, <italic>CLCA1</italic>, <bold><italic>D4S234E</italic>,</bold>
<italic>DDO</italic>, <bold><italic>HUNK</italic>,</bold>
<italic>KIRREL3</italic>, <bold><italic>LMO3</italic>,</bold>
<italic>PLIN4</italic>, <bold><italic>PODXL2</italic>,</bold>
<italic>POSTN</italic>, <italic>SCUBE1</italic>, <bold><italic>SLC41A2</italic>, <italic>TDRD7</italic></bold></td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell-To-Cell Signaling and Interaction, Nervous System Development and Function, Behaviour</td><td align="left" rowspan="1" colspan="1"><bold><italic>ANXA3</italic>,</bold>
<italic>ASL</italic>, <bold><italic>BCO2</italic>,</bold>
<italic>DENND2A</italic>, <bold><italic>FADS3</italic>,</bold>
<italic>FMOD</italic>, <italic>GLS2</italic>, <bold><italic>HUNK</italic>, <italic>IGSF6</italic>, <italic>KLHDC8B</italic>, <italic>LYPD1</italic>, <italic>LYSMD2</italic>, <italic>RTP4</italic>,</bold>
<italic>STS</italic>, <bold><italic>TRIB2</italic></bold></td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">15</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p><sup>&#x02021;</sup>Genes more highly expressed in the Suffolk breed are in bold while gene that are more highly expressed s in the Texel breed are in normal typeface.</p></fn></table-wrap-foot></table-wrap><p>Exploring the roles of these specific genes, pathways and the network in more detail, it is evident that in a GIN-free environment, the Suffolk lambs had greater expression of a number of cytosolic pattern recognition receptors, membrane bound receptors, transcription factors and IFN-induced proteins than Texel lambs. Interestingly, a number of DE genes are assigned to more than one of these pathways (e.g., <italic>RIG-I</italic>, <italic>MDA-5</italic>, <italic>STAT2</italic>, <italic>IRF-3</italic>, <italic>IRF-9</italic>, <italic>OAS1</italic>), indicating that there is overlap between the pathways. These molecules are normally associated with the T helper cell type 1 (Th1) response to viral and/or bacterial exposure [<xref rid="pone.0124823.ref025" ref-type="bibr">25</xref>&#x02013;<xref rid="pone.0124823.ref028" ref-type="bibr">28</xref>]. A variety of pattern recognition receptors (PRRs) were more highly expressed in the Suffolk lambs relative to the Texel lambs. PRRs are a primitive component of the innate immune system. They recognise microbe-specific molecules (pathogen associated molecular patterns; PAMPS), including viral RNA/DNA, lipopolysaccaride, mannose, bacterial peptides, peptidoglycans, lipoproteins and fungal glucans [<xref rid="pone.0124823.ref026" ref-type="bibr">26</xref>&#x02013;<xref rid="pone.0124823.ref029" ref-type="bibr">29</xref>]. They can be located intracellularly, extracellularly, or membrane bound. The gene expression of three cytosolic PRRs (RIG-I, MDA-5 and DAI) was higher in the Suffolk lambs than in Texel lambs. Both RIG-I and MDA-5 belong to the RIG-1-like receptor family, whose members act as sensors of viral RNA. As represented in <xref rid="pone.0124823.g003" ref-type="fig">Fig 3</xref>, upon binding to viral RNA, these receptors induce type-1 interferon (IFN) production via serine/threonine-protein kinase (TBK1), interferon regulatory factor-3 (IRF-3) and ISG-15 [<xref rid="pone.0124823.ref026" ref-type="bibr">26</xref>]. The PRR DAI binds to microbial dsDNA, which induces type-1 interferon production via TBK1 and IRF-3 [<xref rid="pone.0124823.ref027" ref-type="bibr">27</xref>]. Hence, activation of any of these three PRRs leads to the production of IFN, which in turn activates a cluster of IFN-induced proteins, including a number of those genes that were more highly expressed in the Suffolk lambs: <italic>IFIT1</italic>, <italic>IFIT3</italic> and <italic>MX1</italic> which are activated via the transcription factors STAT2 and IRF9 [<xref rid="pone.0124823.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0124823.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0124823.ref031" ref-type="bibr">31</xref>]. It has previously been reported that the IRF9 protein binds with STAT2 protein to produce a set of IFN-induced proteins IFIT3, IFIT1, OAS1, OAS2 and MX1 to activate non-specific anti-viral immunity [<xref rid="pone.0124823.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0124823.ref033" ref-type="bibr">33</xref>]. In fact polymorphisms in the <italic>OAS1</italic> gene are associated with host susceptibility to various diseases [<xref rid="pone.0124823.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0124823.ref035" ref-type="bibr">35</xref>] and with resistance to viral infections [<xref rid="pone.0124823.ref036" ref-type="bibr">36</xref>].</p><p>The genes coding for two membrane-bound PRRs (DECTIN-2 and C3AR1) were also more highly expressed in the Suffolk. DECTIN-2 is a PRR that stimulates non-specific antifungal immunity [<xref rid="pone.0124823.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0124823.ref038" ref-type="bibr">38</xref>] and upon activation mediates a Th2 immune response [<xref rid="pone.0124823.ref039" ref-type="bibr">39</xref>]. There was, however, no evidence that the downstream effector molecules of DECTIN-2 (ERK, NFkB or JNK) were differentially expressed between the breeds (<xref rid="pone.0124823.t004" ref-type="table">Table 4</xref>). C3AR1 is a receptor of the complement cascade [<xref rid="pone.0124823.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0124823.ref041" ref-type="bibr">41</xref>], and interestingly, C1QB and C1QC, which are the B and C chains of the first component of the classical complement pathway were more highly expressed in the Suffolk lambs.</p><p>The spectrum of genes in the Th1/IFN network that are being transcribed in the Suffolk breed, suggests that the Suffolk animals are either innately more prepared for a microbial challenge than the Texel animals, or were actually actively responding to a microbial challenge. In exploring the possibility of recent microbial challenge, two approaches were adopted. Firstly, the haematological parameters of both Suffolk and Texel animals were assessed, and secondly, the RNA-seq data was searched for evidence of viral RNA from viral species known to infect sheep, including Schmallenberg virus, bluetongue virus, orf virus and jaagsiekte sheep retrovirus (JSRV). There was no evidence for an active infection based on the haematological parameters evaluated (unpublished data). Interestingly, there was evidence for two types of viral RNA in all the animals with a similar average number of reads in both breeds (JSRV: Suffolk 62&#x000b1;34, Texel 112&#x000b1;32; orf virus: Suffolk 2040&#x000b1;121, Texel 2190&#x000b1;152). It has previously been reported that the exogenous infectious form of JSRV has an endogenous counterpart, which was integrated into the ovine genome prior to the evolution of sheep and goats [<xref rid="pone.0124823.ref042" ref-type="bibr">42</xref>]. The sheep genome has approximately 27 integrated copies of endogenous JSRV that are genomically closely related to JSRV [<xref rid="pone.0124823.ref043" ref-type="bibr">43</xref>]. It is possible that the Suffolk lambs are responding to the products from the integrated JSRV genome and reacting in a manner described for autoimmune diseases [<xref rid="pone.0124823.ref044" ref-type="bibr">44</xref>]. However, the high number of reads aligned with the orf virus genome is highly suggestive of recent or active orf infection. Orf virus specific polymerase chain reaction in the sheep genomic DNA samples from the lymph node showed the presence of orf virus in all the animals (<xref rid="pone.0124823.g007" ref-type="fig">Fig 7</xref>). Viral DNA may be integrated with the genome of the animals and carried over within the cell during the life of the animals All of the animals used in this study received a fully virulent live virus vaccine (Scabivax, Intervet Ireland) during the first week of life. A recent study detected orf viral DNA in reindeer lymph nodes 4 weeks post experimental inoculation [<xref rid="pone.0124823.ref045" ref-type="bibr">45</xref>]. Within the confines of the current experiment, it was not possible to determine if either of these viruses are responsible for the immune profile in the Suffolk lambs. However, it is worth considering in our future studies particularly the alignment of this sequence data with <italic>Ovine</italic> genome are likely to reveal greater details on the nature of adaptive and innate immune system of these two breeds.</p><fig id="pone.0124823.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0124823.g007</object-id><label>Fig 7</label><caption><title>Polymerase chain reaction amplification of the 594 base pair region of major envelop protein (B2L) gene of orf virus isolate SV178/12 in Suffolk (Lane 1 to 4) and Texel (Lane 5 to 9) animals.</title><p>M- molecular weight marker.</p></caption><graphic xlink:href="pone.0124823.g007"/></fig><p>In conclusion, the analysis of the RNA transcriptome of Suffolk and Texel lambs maintained under GIN-free conditions, suggests that Suffolk sheep have a more active antiviral/antibacterial immune profile than Texels. It is likely that this profile contributes to the variation between the two breeds in their capacity to mount a timely and effective immune response when exposed to a gastrointestinal nematode challenge.</p></sec></sec></sec></body><back><ack><p>The authors gratefully acknowledge the technical assistance of Henry Walsh and Assumpta Glynn, and the farm staff at the Teagasc Research Centre, Athenry for animal care.</p></ack><ref-list><title>References</title><ref id="pone.0124823.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Sayers</surname><given-names>G</given-names></name>, <name><surname>Sweeney</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>Gastrointestinal nematode infection in sheep&#x02014;a review of the alternatives to anthelmintics in parasite control</article-title>. <source>Animal Health Research Reviews</source><volume>6</volume>: <fpage>159</fpage>&#x02013;<lpage>171</lpage>
<?supplied-pmid 16583780?><pub-id pub-id-type="pmid">16583780</pub-id></mixed-citation></ref><ref id="pone.0124823.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Good</surname><given-names>B</given-names></name>, <name><surname>Hanrahan</surname><given-names>J</given-names></name>, <name><surname>Crowley</surname><given-names>B</given-names></name>, <name><surname>Mulcahy</surname><given-names>G</given-names></name> (<year>2006</year>) <article-title>Texel sheep are more resistant to natural nematode challenge than Suffolk sheep based on faecal egg count and nematode burden</article-title>. <source>Veterinary Parasitology</source><volume>136</volume>: <fpage>317</fpage>&#x02013;<lpage>327</lpage>
<?supplied-pmid 16414193?><pub-id pub-id-type="pmid">16414193</pub-id></mixed-citation></ref><ref id="pone.0124823.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Mugambi</surname><given-names>J</given-names></name>, <name><surname>Bain</surname><given-names>R</given-names></name>, <name><surname>Wanyangu</surname><given-names>S</given-names></name>, <name><surname>Ihiga</surname><given-names>M</given-names></name>, <name><surname>Duncan</surname><given-names>J</given-names></name>, <name><surname>Murray</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Resistance of four sheep breeds to natural and subsequent artificial <italic>Haemonchus contortus</italic> infection</article-title>. <source>Veterinary Parasitology</source><volume>69</volume>: <fpage>265</fpage>&#x02013;<lpage>273</lpage>
<?supplied-pmid 9195736?><pub-id pub-id-type="pmid">9195736</pub-id></mixed-citation></ref><ref id="pone.0124823.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Amarante</surname><given-names>AFT</given-names></name>, <name><surname>Bricarello</surname><given-names>P</given-names></name>, <name><surname>Rocha</surname><given-names>R</given-names></name>, <name><surname>Gennari</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>Resistance of Santa Ines, Suffolk and Ile de France sheep to naturally acquired gastrointestinal nematode infections</article-title>. <source>Veterinary Parasitology</source><volume>120</volume>: <fpage>91</fpage>&#x02013;<lpage>106</lpage>
<?supplied-pmid 15019147?><pub-id pub-id-type="pmid">15019147</pub-id></mixed-citation></ref><ref id="pone.0124823.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Hassan</surname><given-names>M</given-names></name>, <name><surname>Good</surname><given-names>B</given-names></name>, <name><surname>Hanrahan</surname><given-names>JP</given-names></name>, <name><surname>Campion</surname><given-names>D</given-names></name>, <name><surname>Sayers</surname><given-names>G</given-names></name>, <name><surname>Mulcahy</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>The dynamic influence of the <italic>DRB1* 1101</italic> allele on the resistance of sheep to experimental <italic>Teladorsagia circumcincta</italic> infection</article-title>. <source>Veterinary Research</source><volume>42</volume>: <fpage>46</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1297-9716-42-46">10.1186/1297-9716-42-46</ext-link></comment><?supplied-pmid 21385412?><pub-id pub-id-type="pmid">21385412</pub-id></mixed-citation></ref><ref id="pone.0124823.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Pemberton</surname><given-names>J</given-names></name>, <name><surname>Beraldi</surname><given-names>D</given-names></name>, <name><surname>Craig</surname><given-names>B</given-names></name>, <name><surname>Hopkins</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>Digital gene expression analysis of gastrointestinal helminth resistance in Scottish Blackface lambs</article-title>. <source>Molecular Ecology</source><volume>20</volume>: <fpage>910</fpage>&#x02013;<lpage>919</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-294X.2010.04992.x">10.1111/j.1365-294X.2010.04992.x</ext-link></comment><?supplied-pmid 21324010?><pub-id pub-id-type="pmid">21324010</pub-id></mixed-citation></ref><ref id="pone.0124823.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Schwaiger</surname><given-names>FW</given-names></name>, <name><surname>Gostomski</surname><given-names>D</given-names></name>, <name><surname>Stear</surname><given-names>M</given-names></name>, <name><surname>Duncan</surname><given-names>J</given-names></name>, <name><surname>McKellar</surname><given-names>Q</given-names></name>, <name><surname>Epplen</surname><given-names>JT</given-names></name>, <etal>et al</etal> (<year>1995</year>) <article-title>An ovine Major histocompatibility complex DRB1 allele is associated with low faecal egg counts following natural, predominantly <italic>Ostertagia circumcincta</italic> infection</article-title>. <source>International Journal for Parasitology</source><volume>25</volume>: <fpage>815</fpage>&#x02013;<lpage>822</lpage>
<?supplied-pmid 7558567?><pub-id pub-id-type="pmid">7558567</pub-id></mixed-citation></ref><ref id="pone.0124823.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Buitkamp</surname><given-names>J</given-names></name>, <name><surname>Filmether</surname><given-names>P</given-names></name>, <name><surname>Stear</surname><given-names>MJ</given-names></name>, <name><surname>Epplen</surname><given-names>JT</given-names></name> (<year>1996</year>) <article-title>Class I and class II Major histocompatibility complex alleles are associated with faecal egg counts following natural, predominantly <italic>Ostertagia circumcincta</italic> infection</article-title>. <source>Parasitology Research</source><volume>82</volume>: <fpage>693</fpage>&#x02013;<lpage>696</lpage>
<?supplied-pmid 8897503?><pub-id pub-id-type="pmid">8897503</pub-id></mixed-citation></ref><ref id="pone.0124823.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Stear</surname><given-names>M</given-names></name>, <name><surname>Bairden</surname><given-names>K</given-names></name>, <name><surname>Bishop</surname><given-names>S</given-names></name>, <name><surname>Buitkamp</surname><given-names>J</given-names></name>, <name><surname>Epplen</surname><given-names>J</given-names></name>, <name><surname>Gostomski</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>An ovine lymphocyte antigen is associated with reduced faecal egg counts in four-month-old lambs following natural, predominantly <italic>Ostertagia circumcincta</italic> infection</article-title>. <source>International Journal for Parasitology</source><volume>26</volume>: <fpage>423</fpage>&#x02013;<lpage>428</lpage>
<?supplied-pmid 8773530?><pub-id pub-id-type="pmid">8773530</pub-id></mixed-citation></ref><ref id="pone.0124823.ref010"><label>10</label><mixed-citation publication-type="other">Crawford A, McEwan J (1998) Identification of animals resistant to nematode parasite infection. New Zealand Provisional Patent 330201.</mixed-citation></ref><ref id="pone.0124823.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Coltman</surname><given-names>D</given-names></name>, <name><surname>Wilson</surname><given-names>K</given-names></name>, <name><surname>Pilkington</surname><given-names>J</given-names></name>, <name><surname>Stear</surname><given-names>M</given-names></name>, <name><surname>Pemberton</surname><given-names>J</given-names></name> (<year>2001</year>) <article-title>A microsatellite polymorphism in the gamma interferon gene is associated with resistance to gastrointestinal nematodes in a naturally-parasitized population of Soay sheep</article-title>. <source>Parasitology</source><volume>122</volume>: <fpage>571</fpage>&#x02013;<lpage>582</lpage>
<?supplied-pmid 11393831?><pub-id pub-id-type="pmid">11393831</pub-id></mixed-citation></ref><ref id="pone.0124823.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Keane</surname><given-names>OM</given-names></name>, <name><surname>Amonida</surname><given-names>Z</given-names></name>, <name><surname>Theresa</surname><given-names>W</given-names></name>, <name><surname>Dianne</surname><given-names>H</given-names></name>, <name><surname>Gordon</surname><given-names>G</given-names></name>, <name><surname>Baird</surname><given-names>DB</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Gene expression profiling of naive sheep genetically resistant and susceptible to gastrointestinal nematodes</article-title>. <source>BMC Genomics</source><volume>7</volume>: <fpage>42</fpage>
<?supplied-pmid 16515715?><pub-id pub-id-type="pmid">16515715</pub-id></mixed-citation></ref><ref id="pone.0124823.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Keane</surname><given-names>OM</given-names></name>, <name><surname>Dodds</surname><given-names>KG</given-names></name>, <name><surname>Crawford</surname><given-names>AM</given-names></name>, <name><surname>McEwan</surname><given-names>JC</given-names></name> (<year>2007</year>) <article-title>Transcriptional profiling of Ovis aries identifies Ovar-DQA1 allele frequency differences between nematode-resistant and susceptible selection lines</article-title>. <source>Physiological Genomics 2007</source>, <volume>30</volume>(<issue>3</issue>):<fpage>253</fpage>&#x02013;<lpage>261</lpage>
<?supplied-pmid 17488886?><pub-id pub-id-type="pmid">17488886</pub-id></mixed-citation></ref><ref id="pone.0124823.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Sayers</surname><given-names>G</given-names></name>, <name><surname>Good</surname><given-names>B</given-names></name>, <name><surname>Hanrahan</surname><given-names>J</given-names></name>, <name><surname>O'Donovan</surname><given-names>J</given-names></name>, <name><surname>Mulcahy</surname><given-names>G</given-names></name>, <name><surname>Sweeney</surname><given-names>T</given-names></name>(<year>2008</year>) <article-title>Breed differences in mucosal and systemic antibody response to nematode infection in sheep: an important role for IgE?</article-title><source>Parasitology</source><volume>135</volume>: <fpage>71</fpage>&#x02013;<lpage>80</lpage>
<?supplied-pmid 17903317?><pub-id pub-id-type="pmid">17903317</pub-id></mixed-citation></ref><ref id="pone.0124823.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>AM</given-names></name>, <name><surname>Sebastiano</surname><given-names>SR</given-names></name>, <name><surname>Sweeney</surname><given-names>T</given-names></name>, <name><surname>Hanrahan</surname><given-names>JP</given-names></name>, <name><surname>Glynn</surname><given-names>A</given-names></name>, <name><surname>Keane</surname><given-names>OM</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Breed differences in humoral and cellular responses of lambs to experimental infection with the gastrointestinal nematode <italic>Teladorsagia circumcincta</italic></article-title>. <source>Veterinary Research</source><volume>46</volume>: <fpage>8</fpage> (<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s13567-014-0137-0">10.1186/s13567-014-0137-0</ext-link></comment>) <?supplied-pmid 25827901?><pub-id pub-id-type="pmid">25827901</pub-id></mixed-citation></ref><ref id="pone.0124823.ref016"><label>16</label><mixed-citation publication-type="other">Andrews S, Fast QC. A quality control tool for high throughput sequence data. Available: <ext-link ext-link-type="uri" xlink:href="http://wwwbioinformaticsbbsrcacuk/projects/fastqc/">http://wwwbioinformaticsbbsrcacuk/projects/fastqc/</ext-link>.</mixed-citation></ref><ref id="pone.0124823.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Ewing</surname><given-names>B</given-names></name>, <name><surname>Green</surname><given-names>P</given-names></name> (<year>1998</year>) <article-title>Base-calling of automated sequencer traces using Phred. II. error probabilities</article-title>. <source>Genome Research</source><volume>8</volume>: <fpage>186</fpage>&#x02013;<lpage>194</lpage>
<?supplied-pmid 9521922?><pub-id pub-id-type="pmid">9521922</pub-id></mixed-citation></ref><ref id="pone.0124823.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Langmead</surname><given-names>B</given-names></name>, <name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Pop</surname><given-names>M</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name> (<year>2009</year>) <article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>. <source>Genome Biology</source><volume>10</volume>: <fpage>R25</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2009-10-3-r25">10.1186/gb-2009-10-3-r25</ext-link></comment><?supplied-pmid 19261174?><pub-id pub-id-type="pmid">19261174</pub-id></mixed-citation></ref><ref id="pone.0124823.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Homer</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>The sequence alignment/map format and SAMtools</article-title>. <source>Bioinformatics</source><volume>25</volume>: <fpage>2078</fpage>&#x02013;<lpage>2079</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btp352">10.1093/bioinformatics/btp352</ext-link></comment><?supplied-pmid 19505943?><pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation></ref><ref id="pone.0124823.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>McCarthy</surname><given-names>DJ</given-names></name>, <name><surname>Smyth</surname><given-names>GK</given-names></name> (<year>2010</year>) <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source><volume>26</volume>: <fpage>139</fpage>&#x02013;<lpage>140</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btp616">10.1093/bioinformatics/btp616</ext-link></comment><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation></ref><ref id="pone.0124823.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>Oshlack</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>A scaling normalization method for differential expression analysis of RNA-seq data</article-title>. <source>Genome Biology</source><volume>11</volume>: <fpage>R25</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2010-11-3-r25">10.1186/gb-2010-11-3-r25</ext-link></comment><?supplied-pmid 20196867?><pub-id pub-id-type="pmid">20196867</pub-id></mixed-citation></ref><ref id="pone.0124823.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Zambon</surname><given-names>AC</given-names></name>, <name><surname>Gaj</surname><given-names>S</given-names></name>, <name><surname>Ho</surname><given-names>I</given-names></name>, <name><surname>Hanspers</surname><given-names>K</given-names></name>, <name><surname>Vranizan</surname><given-names>K</given-names></name>, <name><surname>Evelo</surname><given-names>CT</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>GO-Elite: a flexible solution for pathway and ontology over-representation</article-title>. <source>Bioinformatics</source><volume>28</volume>: <fpage>2209</fpage>&#x02013;<lpage>2210</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/bts366">10.1093/bioinformatics/bts366</ext-link></comment><?supplied-pmid 22743224?><pub-id pub-id-type="pmid">22743224</pub-id></mixed-citation></ref><ref id="pone.0124823.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Inoshima</surname><given-names>Y</given-names></name>, <name><surname>Morooka</surname><given-names>A</given-names></name>, <name><surname>Sentsu</surname><given-names>H</given-names></name> (<year>2000</year>) <article-title>Detection and diagnosis of paraposvirus by the polymerase chain reaction</article-title>. <source>Journal of Virological Methods</source><volume>84</volume>:<fpage>201</fpage>&#x02013;<lpage>208</lpage>
<?supplied-pmid 10680970?><pub-id pub-id-type="pmid">10680970</pub-id></mixed-citation></ref><ref id="pone.0124823.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Hellemans</surname><given-names>J</given-names></name>, <name><surname>Mortier</surname><given-names>G</given-names></name>, <name><surname>De Paepe</surname><given-names>A</given-names></name>, <name><surname>Speleman</surname><given-names>F</given-names></name>, <name><surname>Vandesompele</surname><given-names>J</given-names></name> (<year>2007</year>) <article-title>qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data</article-title>. <source>Genome Biology</source><volume>8</volume>: <fpage>R19</fpage>
<?supplied-pmid 17291332?><pub-id pub-id-type="pmid">17291332</pub-id></mixed-citation></ref><ref id="pone.0124823.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Yoneyama</surname><given-names>M</given-names></name>, <name><surname>Kikuchi</surname><given-names>M</given-names></name>, <name><surname>Matsumoto</surname><given-names>K</given-names></name>, <name><surname>Imaizumi</surname><given-names>T</given-names></name>, <name><surname>Miyagishi</surname><given-names>M</given-names></name>, <name><surname>Taira</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity</article-title>. <source>The Journal of Immunology</source><volume>175</volume>: <fpage>2851</fpage>&#x02013;<lpage>2858</lpage>
<?supplied-pmid 16116171?><pub-id pub-id-type="pmid">16116171</pub-id></mixed-citation></ref><ref id="pone.0124823.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Yoneyama</surname><given-names>M</given-names></name>, <name><surname>Kikuchi</surname><given-names>M</given-names></name>, <name><surname>Natsukawa</surname><given-names>T</given-names></name>, <name><surname>Shinobu</surname><given-names>N</given-names></name>, <name><surname>Imaizumi</surname><given-names>T</given-names></name>, <name><surname>Miyagishi</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses</article-title>. <source>Nature Immunology</source><volume>5</volume>: <fpage>730</fpage>&#x02013;<lpage>737</lpage>
<?supplied-pmid 15208624?><pub-id pub-id-type="pmid">15208624</pub-id></mixed-citation></ref><ref id="pone.0124823.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Takaoka</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>ZC</given-names></name>, <name><surname>Choi</surname><given-names>MK</given-names></name>, <name><surname>Yanai</surname><given-names>H</given-names></name>, <name><surname>Negishi</surname><given-names>H</given-names></name>, <name><surname>Ban</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response</article-title>. <source>Nature</source><volume>448</volume>: <fpage>501</fpage>&#x02013;<lpage>505</lpage>
<?supplied-pmid 17618271?><pub-id pub-id-type="pmid">17618271</pub-id></mixed-citation></ref><ref id="pone.0124823.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Biacchesi</surname><given-names>S</given-names></name>, <name><surname>LeBerre</surname><given-names>M</given-names></name>, <name><surname>Lamoureux</surname><given-names>A</given-names></name>, <name><surname>Louise</surname><given-names>Y</given-names></name>, <name><surname>Lauret</surname><given-names>E</given-names></name>, <name><surname>Boudinot</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Mitochondrial antiviral signaling protein plays a major role in induction of the fish innate immune response against RNA and DNA viruses</article-title>. <source>Journal of Virology</source><volume>83</volume>: <fpage>7815</fpage>&#x02013;<lpage>7827</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.00404-09">10.1128/JVI.00404-09</ext-link></comment><?supplied-pmid 19474100?><pub-id pub-id-type="pmid">19474100</pub-id></mixed-citation></ref><ref id="pone.0124823.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Poeck</surname><given-names>H</given-names></name>, <name><surname>Bscheider</surname><given-names>M</given-names></name>, <name><surname>Gross</surname><given-names>O</given-names></name>, <name><surname>Finger</surname><given-names>K</given-names></name>, <name><surname>Roth</surname><given-names>S</given-names></name>, <name><surname>Rebsamen</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 [beta] production</article-title>. <source>Nature Immunology</source><volume>11</volume>: <fpage>63</fpage>&#x02013;<lpage>69</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ni.1824">10.1038/ni.1824</ext-link></comment><?supplied-pmid 19915568?><pub-id pub-id-type="pmid">19915568</pub-id></mixed-citation></ref><ref id="pone.0124823.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>H</given-names></name>, <name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Sato</surname><given-names>S</given-names></name>, <name><surname>Yoneyama</surname><given-names>M</given-names></name>, <name><surname>Yamamoto</surname><given-names>M</given-names></name>, <name><surname>Matsui</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses</article-title>. <source>Nature</source><volume>441</volume>: <fpage>101</fpage>&#x02013;<lpage>105</lpage>
<?supplied-pmid 16625202?><pub-id pub-id-type="pmid">16625202</pub-id></mixed-citation></ref><ref id="pone.0124823.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Kraus</surname><given-names>TA</given-names></name>, <name><surname>Lau</surname><given-names>JF</given-names></name>, <name><surname>Parisien</surname><given-names>JP</given-names></name>, <name><surname>Horvath</surname><given-names>CM</given-names></name> (<year>2003</year>) <article-title>A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response</article-title>. <source>Journal of Biological Chemistry</source><volume>278</volume>: <fpage>13033</fpage>&#x02013;<lpage>13038</lpage>
<?supplied-pmid 12574168?><pub-id pub-id-type="pmid">12574168</pub-id></mixed-citation></ref><ref id="pone.0124823.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Pichlmair</surname><given-names>A</given-names></name>, <name><surname>Lassnig</surname><given-names>C</given-names></name>, <name><surname>Eberle</surname><given-names>CA</given-names></name>, <name><surname>G&#x000f3;rna</surname><given-names>MW</given-names></name>, <name><surname>Baumann</surname><given-names>CL</given-names></name>, <name><surname>Burkard</surname><given-names>TR</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>IFIT1 is an antiviral protein that recognizes 5 [prime]-triphosphate RNA</article-title>. <source>Nature Immunology</source><volume>12</volume>: <fpage>624</fpage>&#x02013;<lpage>630</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ni.2048">10.1038/ni.2048</ext-link></comment><?supplied-pmid 21642987?><pub-id pub-id-type="pmid">21642987</pub-id></mixed-citation></ref><ref id="pone.0124823.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>O'Brien</surname><given-names>M</given-names></name>, <name><surname>Lonergan</surname><given-names>R</given-names></name>, <name><surname>Costelloe</surname><given-names>L</given-names></name>, <name><surname>O'Rourke</surname><given-names>K</given-names></name>, <name><surname>Fletcher</surname><given-names>J</given-names></name>, <name><surname>Kinsella</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>OAS1 A multiple sclerosis susceptibility gene that influences disease severity</article-title>. <source>Neurology</source><volume>75</volume>: <fpage>411</fpage>&#x02013;<lpage>418</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1212/WNL.0b013e3181ebdd2b">10.1212/WNL.0b013e3181ebdd2b</ext-link></comment><?supplied-pmid 20679634?><pub-id pub-id-type="pmid">20679634</pub-id></mixed-citation></ref><ref id="pone.0124823.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Rios</surname><given-names>JJ</given-names></name>, <name><surname>Fleming</surname><given-names>JAGW</given-names></name>, <name><surname>Bryant</surname><given-names>UK</given-names></name>, <name><surname>Carter</surname><given-names>CN</given-names></name>, <name><surname>Huber</surname><given-names>JC</given-names></name>, <name><surname>Long</surname><given-names>MT</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses</article-title>. <source>PLoS One</source><volume>5</volume>: <fpage>e10537</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0010537">10.1371/journal.pone.0010537</ext-link></comment><?supplied-pmid 20479874?><pub-id pub-id-type="pmid">20479874</pub-id></mixed-citation></ref><ref id="pone.0124823.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Cagliani</surname><given-names>R</given-names></name>, <name><surname>Fumagalli</surname><given-names>M</given-names></name>, <name><surname>Guerini</surname><given-names>FR</given-names></name>, <name><surname>Riva</surname><given-names>S</given-names></name>, <name><surname>Galimberti</surname><given-names>D</given-names></name>, <name><surname>Comi</surname><given-names>GP</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis</article-title>. <source>Human Genetics</source>: <volume>131</volume>: <fpage>87</fpage>&#x02013;<lpage>97</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00439-011-1053-2">10.1007/s00439-011-1053-2</ext-link></comment><?supplied-pmid 21735172?><pub-id pub-id-type="pmid">21735172</pub-id></mixed-citation></ref><ref id="pone.0124823.ref036"><label>36</label><mixed-citation publication-type="other">Scherer CA, Rosenberg G, Magness CL, Iadonato SP, Guillaudeux T (2009) Detection of mutations in a gene associated with resistance to viral infection, oas1. EP Patent 2,083,089.</mixed-citation></ref><ref id="pone.0124823.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Saijo</surname><given-names>S</given-names></name>, <name><surname>Iwakura</surname><given-names>Y</given-names></name> (<year>2011</year>) <article-title>Dectin-1 and Dectin-2 in innate immunity against fungi</article-title>. <source>International Immunology</source><volume>23</volume>: <fpage>467</fpage>&#x02013;<lpage>472</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/intimm/dxr046">10.1093/intimm/dxr046</ext-link></comment><?supplied-pmid 21677049?><pub-id pub-id-type="pmid">21677049</pub-id></mixed-citation></ref><ref id="pone.0124823.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Hollmig</surname><given-names>ST</given-names></name>, <name><surname>Ariizumi</surname><given-names>K</given-names></name>, <name><surname>Cruz</surname><given-names>PD</given-names><suffix>Jr</suffix></name> (<year>2009</year>) <article-title>Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2</article-title>. <source>Glycobiology</source><volume>19</volume>: <fpage>568</fpage>&#x02013;<lpage>575</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/glycob/cwp032">10.1093/glycob/cwp032</ext-link></comment><?supplied-pmid 19287024?><pub-id pub-id-type="pmid">19287024</pub-id></mixed-citation></ref><ref id="pone.0124823.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Barrett</surname><given-names>NA</given-names></name>, <name><surname>Rahman</surname><given-names>OM</given-names></name>, <name><surname>Fernandez</surname><given-names>JM</given-names></name>, <name><surname>Parsons</surname><given-names>MW</given-names></name>, <name><surname>Xing</surname><given-names>W</given-names></name>, <name><surname>Austen</surname><given-names>KF</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes</article-title>. <source>The Journal of Experimental Medicine</source><volume>208</volume>: <fpage>593</fpage>&#x02013;<lpage>604</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20100793">10.1084/jem.20100793</ext-link></comment><?supplied-pmid 21357742?><pub-id pub-id-type="pmid">21357742</pub-id></mixed-citation></ref><ref id="pone.0124823.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Baruah</surname><given-names>P</given-names></name>, <name><surname>Dumitriu</surname><given-names>IE</given-names></name>, <name><surname>Malik</surname><given-names>TH</given-names></name>, <name><surname>Cook</surname><given-names>HT</given-names></name>, <name><surname>Dyson</surname><given-names>J</given-names></name>, <name><surname>Scott</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>C1q enhances IFN-&#x003b3; production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells</article-title>. <source>Blood</source><volume>113</volume>: <fpage>3485</fpage>&#x02013;<lpage>3493</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2008-06-164392">10.1182/blood-2008-06-164392</ext-link></comment><?supplied-pmid 19171874?><pub-id pub-id-type="pmid">19171874</pub-id></mixed-citation></ref><ref id="pone.0124823.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Kawamoto</surname><given-names>S</given-names></name>, <name><surname>Yalcindag</surname><given-names>A</given-names></name>, <name><surname>Laouini</surname><given-names>D</given-names></name>, <name><surname>Brodeur</surname><given-names>S</given-names></name>, <name><surname>Bryce</surname><given-names>P</given-names></name>, <name><surname>Lu</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen</article-title>. <source>Journal of Clinical Investigation</source><volume>114</volume>: <fpage>399</fpage>&#x02013;<lpage>407</lpage>
<?supplied-pmid 15286806?><pub-id pub-id-type="pmid">15286806</pub-id></mixed-citation></ref><ref id="pone.0124823.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Chessa</surname><given-names>B</given-names></name>, <name><surname>Pereira</surname><given-names>F</given-names></name>, <name><surname>Arnaud</surname><given-names>F</given-names></name>, <name><surname>Amorim</surname><given-names>A</given-names></name>, <name><surname>Goyache</surname><given-names>F</given-names></name>, <name><surname>Mainland</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Revealing the history of sheep domestication using retrovirus integrations</article-title>. <source>Science</source><volume>324</volume>: <fpage>532</fpage>&#x02013;<lpage>536</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1170587">10.1126/science.1170587</ext-link></comment><?supplied-pmid 19390051?><pub-id pub-id-type="pmid">19390051</pub-id></mixed-citation></ref><ref id="pone.0124823.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>TE</given-names></name>, <name><surname>Palmarini</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Application of next generation sequencing in mammalian embryogenomics: Lessons learned from endogenous betaretroviruses of sheep</article-title>. <source>Animal Reproduction Science</source><volume>134</volume>: <fpage>95</fpage>&#x02013;<lpage>103</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.anireprosci.2012.08.016">10.1016/j.anireprosci.2012.08.016</ext-link></comment><?supplied-pmid 22951118?><pub-id pub-id-type="pmid">22951118</pub-id></mixed-citation></ref><ref id="pone.0124823.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Uematsu</surname><given-names>S</given-names></name>, <name><surname>Akira</surname><given-names>S</given-names></name> (<year>2006</year>) <article-title>The role of Toll-like receptors in immune disorders</article-title>. <source>Expert Opinion Biological Therapy</source><volume>6</volume>: <fpage>203</fpage>&#x02013;<lpage>214</lpage>
<?supplied-pmid 16503731?><pub-id pub-id-type="pmid">16503731</pub-id></mixed-citation></ref><ref id="pone.0124823.ref045"><label>45</label><mixed-citation publication-type="other">Tryland M, Klein J, Berger T, Josefsen TD, Neves CG, Oksanen A, et al. (2012) Experimental parapoxvirus infection (contagious ecthyma) in semi-domesticated reindeer (<italic>Rangifer tarandus tarandus)</italic> Veterinary Microbiology. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vet-mic.2012.10.039">http://dx.doi.org/10.1016/j.vet-mic.2012.10.039</ext-link></mixed-citation></ref></ref-list></back></article>